{"id":"methylcellulose-0-5","safety":{"commonSideEffects":[{"rate":null,"effect":"Blurred vision"},{"rate":null,"effect":"Eye irritation or stinging"},{"rate":null,"effect":"Mild conjunctival hyperemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methylcellulose is a cellulose derivative that forms a protective, hydrophilic film on the cornea and conjunctiva. It increases tear viscosity and promotes tear film retention, thereby reducing ocular surface irritation and providing lubrication. It is commonly used as an artificial tear substitute for symptomatic relief of dry eye.","oneSentence":"Methylcellulose is a viscous lubricant that coats and protects the ocular surface by increasing tear film stability and reducing friction.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:34:34.908Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye syndrome / keratoconjunctivitis sicca"},{"name":"Ocular surface irritation and discomfort"}]},"trialDetails":[{"nctId":"NCT06859476","phase":"PHASE4","title":"Evaluation of Manzanilla® and Meticel Ofteno® 0.5% for Providing a Relief Sensation to the Eyes","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2025-05-23","conditions":"Ophthalmological Agent Toxicity","enrollment":168},{"nctId":"NCT05285878","phase":"PHASE2","title":"Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation","status":"ENROLLING_BY_INVITATION","sponsor":"The Methodist Hospital Research Institute","startDate":"2022-07-28","conditions":"Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection","enrollment":20},{"nctId":"NCT02544529","phase":"PHASE4","title":"Echothiophate Iodide for the Prevention of Progression of Myopia","status":"WITHDRAWN","sponsor":"Danbury Eye Physicians & Surgeons, PC","startDate":"2016-06-01","conditions":"Myopia","enrollment":""},{"nctId":"NCT06601101","phase":"PHASE3","title":"Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus","status":"RECRUITING","sponsor":"University of Campinas, Brazil","startDate":"2024-08-01","conditions":"Keratoconus, Cornea Disease, Eye Diseases","enrollment":36},{"nctId":"NCT02340962","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection","status":"COMPLETED","sponsor":"TaiGen Biotechnology Co., Ltd.","startDate":"2015-05","conditions":"Hepatitis C, Chronic","enrollment":25},{"nctId":"NCT05924893","phase":"NA","title":"The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer","status":"COMPLETED","sponsor":"Minia University","startDate":"2021-01-01","conditions":"Cornea Ulcer","enrollment":50},{"nctId":"NCT05292755","phase":"PHASE4","title":"Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-04-22","conditions":"Dry Eye Syndromes","enrollment":80},{"nctId":"NCT01336634","phase":"PHASE2","title":"Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-08-05","conditions":"Cancer","enrollment":177},{"nctId":"NCT04843839","phase":"PHASE2","title":"CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops","status":"UNKNOWN","sponsor":"L.V. Prasad Eye Institute","startDate":"2020-12-15","conditions":"Congenital Hereditary Endothelial Dystrophy of Cornea","enrollment":30},{"nctId":"NCT02723539","phase":"PHASE1","title":"A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI","status":"COMPLETED","sponsor":"Microbion Corporation","startDate":"2017-03-06","conditions":"Diabetic Foot Infection","enrollment":52},{"nctId":"NCT02117687","phase":"PHASE4","title":"A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eye","status":"COMPLETED","sponsor":"Allergan","startDate":"2014-05-14","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca","enrollment":80},{"nctId":"NCT01924091","phase":"PHASE1","title":"PK/PD of Single Dose Dapivirine Vaginal Film","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-09","conditions":"Pharmaokinetics","enrollment":60},{"nctId":"NCT03009799","phase":"PHASE2","title":"Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)","status":"WITHDRAWN","sponsor":"NicOx","startDate":"2017-01","conditions":"Adenoviral Conjunctivitis","enrollment":""},{"nctId":"NCT00478036","phase":"NA","title":"Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Open Angle Glaucoma","enrollment":31},{"nctId":"NCT00485108","phase":"NA","title":"Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty","status":"COMPLETED","sponsor":"Queen's University","startDate":"2007-01","conditions":"Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma","enrollment":120},{"nctId":"NCT00386646","phase":"PHASE4","title":"Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2004-02","conditions":"Dry Eye Syndromes","enrollment":100},{"nctId":"NCT00938704","phase":"PHASE4","title":"Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-06","conditions":"Dry Eye Syndromes","enrollment":71},{"nctId":"NCT00987727","phase":"PHASE4","title":"Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye","status":"COMPLETED","sponsor":"Allergan","startDate":"2009-11","conditions":"Dry Eye Syndromes, Keratoconjunctivitis Sicca","enrollment":82},{"nctId":"NCT00865540","phase":"PHASE4","title":"Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies","status":"UNKNOWN","sponsor":"Clinica Oftamologica Zona Sul","startDate":"2009-03","conditions":"Cataract","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"methylcellulose 0.5%","genericName":"methylcellulose 0.5%","companyName":"Clinica Oftamologica Zona Sul","companyId":"clinica-oftamologica-zona-sul","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylcellulose is a bulk-forming laxative used to treat various conditions, including dry eye syndromes and diabetic foot infections, as seen in clinical trials on ClinicalTrials.gov. It is also known by various synonyms, such as Cellulose Methyl Ether and Citrucel, as listed in ChEMBL.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}